share_log

Top 3 Health Care Stocks That May Explode This Month

Top 3 Health Care Stocks That May Explode This Month

本月可能爆發的前三家醫療保健股票
Benzinga ·  09/23 19:13

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

醫療保健板塊中最超賣的股票爲買入被低估的公司提供了機會。

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

RSI指標是一種動量指標，它比較了股票在價格上漲時的強度與在價格下跌時的強度。與股票的價格走勢進行比較，可以給交易者更好的了解股票短期內表現的良好程度。當RSI低於30時，資產通常被認爲是超賣的，根據Benzinga Pro的數據。

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

以下是本行業板塊最近的主要超賣股票列表，RSI接近或低於30。

Progyny Inc (NASDAQ:PGNY)

Progyny Inc（NASDAQ：PGNY）

  • On Sept. 19, the company said a client elected to exercise an option to terminate its services agreement with the company. The company's stock fell around 32% over the past five days and has a 52-week low of $13.93.
  • RSI Value: 26.50
  • PGNY Price Action: Shares of Progyny rose 1% to close at $16.62 on Friday.
  • Benzinga Pro's real-time newsfeed alerted to latest PGNY news.
  • 9月19日，該公司表示，一位客戶選擇行使終止與公司的服務協議的選擇權。該公司股價在過去的五天內下跌了約32%，並且52周最低價爲13.93美元。
  • RSI數值: 26.50
  • Progyny價格走勢: Progyny股票週五上漲1%，收盤價爲16.62美元。
  • Benzinga Pro的實時新聞提醒了最新的Progyny新聞。
big

Indivior PLC (NASDAQ:INDV)

Indivior PLC (納斯達克:INDV)

  • On Sept. 4, Indivior issued an update on Aelis Farma's Phase 2B study with AEF0117 in participants with cannabis use disorder. It has a 52-week low of $9.14.
  • RSI Value: 25.92
  • RELI Price Action: Shares of Indivior fell 2.1% to close at $9.48 on Friday.
  • Benzinga Pro's charting tool helped identify the trend in INDV stock.
  • 9月4日，Indivior發佈了有關Aelis Farma進行的AEF0117在大麻使用障礙參與者中進行的第20億階段研究的更新。該股的52周最低價爲$9.14。
  • RSI數值: 25.92
  • RELI價格走勢: Indivior股價週五下跌2.1%，收於$9.48。
  • Benzinga Pro的圖表工具有助於識別INDV股票的趨勢。
big

Moderna Inc (NASDAQ:MRNA)

Moderna Inc (納斯達克:MRNA)

  • On Sept. 17, Moderna announced that Health Canada approved its vaccine, SPIKEVAX, which aids in preventing COVID-19 in people six months of age or older.The vaccine targets the KP.2 variant of COVID-19. The company plans to begin delivery of the vaccine to the Public Health Agency of Canada shortly. "With the recent increase in COVID-19-infections, staying up to date with your COVID-19 vaccination remains one of the best ways to help protect yourself from severe illness," said Dr. Shehzad Iqbal, country medical director, Moderna Canada. The company's shares fell around 20% over the past month and has a 52-week low of $62.55.
  • RSI Value: 28.17
  • MRNA Price Action: Shares of Moderna fell 3.4% to close at $65.69 on Friday.
  • Benzinga Pro's signals feature notified of a potential breakout in MRNA shares.
  • Moderna於9月17日宣佈，加拿大衛生部批准了其名爲SPIKEVAX的疫苗，可幫助預防6個月及以上人群的COVID-19。該疫苗針對COVID-19的KP.2變種。公司計劃不久開始向加拿大公共衛生機構提供疫苗。Moderna加拿大國家醫療董事Shehzad Iqbal博士表示："隨着COVID-19感染率的最近增加，及時接種COVID-19疫苗仍然是幫助保護自己免受重症疾病侵害的最佳途徑。" 過去一個月公司股價下跌約20％，52周最低點爲62.55美元。
  • RSI值：28.17
  • Moderna股價走勢：Moderna股價週五下跌3.4％，收於65.69美元。
  • Benzinga Pro的信號功能顯示MRNA股票可能出現突破。
big
  • Jim Cramer: Viking Has 'Many Ships Coming In'
  • 吉姆·克雷默：維京公司有「多艘船即將到港」

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論